IMPORTANT SAFETY INFORMATION FOR PATIENTS BEING TREATED FOR ASTHMA: Long-acting beta2-adrenergic agonists (LABAs), such as salmeterol, the active ingredient in SEREVENT® DISKUS®, increase the risk of asthma-related death. (See Boxed Warning.) CONTINUED BELOW

Page Not Found

We could not find the page you requested. Use one of the links above to return to the site.

This website is funded and developed by GlaxoSmithKline.
This site is intended for US residents only.
© 1997-2013 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Medicine Savings | Contact Us